414 related articles for article (PubMed ID: 9787367)
21. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
Adamsons IA; Polis A; Ostrov CS; Boyle JE
J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
[TBL] [Abstract][Full Text] [Related]
22. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group.
Silver LH
Am J Ophthalmol; 1998 Sep; 126(3):400-8. PubMed ID: 9744373
[TBL] [Abstract][Full Text] [Related]
23. A six-week dose-response study of the ocular hypotensive effect of dorzolamide with a one-year extension. Dorzolamide Dose-Response Study Group.
Strahlman E; Tipping R; Vogel R
Am J Ophthalmol; 1996 Aug; 122(2):183-94. PubMed ID: 8694086
[TBL] [Abstract][Full Text] [Related]
24. Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol.
Stewart WC; Halper LK; Johnson-Pratt L; Polis A; Hartenbaum D
J Ocul Pharmacol Ther; 2002 Jun; 18(3):211-20. PubMed ID: 12099542
[TBL] [Abstract][Full Text] [Related]
25. Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma.
Eren MH; Gungel H; Altan C; Pasaoglu IB; Sabanci S
J Ocul Pharmacol Ther; 2012 Aug; 28(4):381-6. PubMed ID: 22320418
[TBL] [Abstract][Full Text] [Related]
26. Dorzolamide/Timolol fixed combination versus concomitant administration of brimonidine and timolol in patients with elevated intraocular pressure: a 3-month comparison of efficacy, tolerability, and patient-reported measures.
Solish AM; DeLucca PT; Cassel DA; Kolodny AH; Hustad CM; Skobieranda F
J Glaucoma; 2004 Apr; 13(2):149-57. PubMed ID: 15097262
[TBL] [Abstract][Full Text] [Related]
27. Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma.
Ormrod D; McClellan K
Drugs Aging; 2000 Dec; 17(6):477-96. PubMed ID: 11200308
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
García-López A; Paczka JA; Jiménez-Román J; Hartleben C
BMC Ophthalmol; 2014 Dec; 14():161. PubMed ID: 25527295
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
Shin DH; Feldman RM; Sheu WP;
Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
[TBL] [Abstract][Full Text] [Related]
30. Latanoprost versus combined therapy with timolol plus dorzolamide: IOP-lowering effect in open-angle glaucoma.
Polo V; Larrosa JM; Gomez ML; Pablo L; Honrubia FM
Acta Ophthalmol Scand; 2001 Feb; 79(1):6-9. PubMed ID: 11167277
[TBL] [Abstract][Full Text] [Related]
31. A double-masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol, and betaxolol. Dorzolamide Corneal Effects Study Group.
Lass JH; Khosrof SA; Laurence JK; Horwitz B; Ghosh K; Adamsons I
Arch Ophthalmol; 1998 Aug; 116(8):1003-10. PubMed ID: 9715679
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of dorzolamide, a topical carbonic anhydrase inhibitor, in combination with timolol in the treatment of patients with open-angle glaucoma and ocular hypertension.
Hartenbaum D
Clin Ther; 1996; 18(3):460-5. PubMed ID: 8829021
[TBL] [Abstract][Full Text] [Related]
33. A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life.
Strohmaier K; Snyder E; Adamsons I
J Am Optom Assoc; 1998 Jul; 69(7):441-51. PubMed ID: 9697378
[TBL] [Abstract][Full Text] [Related]
34. Brinzolamide/timolol: in open-angle glaucoma and ocular hypertension.
Croxtall JD; Scott LJ
Drugs Aging; 2009; 26(5):437-46. PubMed ID: 19552495
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized, open-label, multicenter study in Greece.
Petounis A; Mylopoulos N; Kandarakis A; Andreanos D; Dimitrakoulias N
J Glaucoma; 2001 Aug; 10(4):316-24. PubMed ID: 11558817
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the safety and efficacy of the fixed combination of dorzolamide/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study. International Clinical Equivalence Study Group.
Hutzelmann J; Owens S; Shedden A; Adamsons I; Vargas E
Br J Ophthalmol; 1998 Nov; 82(11):1249-53. PubMed ID: 9924327
[TBL] [Abstract][Full Text] [Related]
37. Adjunctive therapy with brinzolamide 1% ophthalmic suspension (Azopt) in patients with open-angle glaucoma or ocular hypertension maintained on timolol therapy.
Shin D
Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S163-8. PubMed ID: 10665519
[TBL] [Abstract][Full Text] [Related]
38. The hypotensive efficacy of dorzolamide HCL-timolol maleate 0.50% vs concomitant use of the two drugs.
Durante A; Aurilia P; Guarnaccia G; Boles Carenini B
Acta Ophthalmol Scand Suppl; 2000; (232):46. PubMed ID: 11235533
[No Abstract] [Full Text] [Related]
39. Comparison of latanoprost monotherapy to dorzolamide combined with timolol in patients with glaucoma and ocular hypertension.A 3-month randomised study.
Emmerich KH
Graefes Arch Clin Exp Ophthalmol; 2000 Jan; 238(1):19-23. PubMed ID: 10664047
[TBL] [Abstract][Full Text] [Related]
40. Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label, parallel-group, multicenter study in Latin America.
; ; . PubMed ID: 15220019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]